Abstract
The release of azidothymidine from macromolecular prodrugs was designed to respond to the intracellular disulfide reshuffling. This drug has no thiol groups, and a response to this trigger was engineered using a self-immolative linker. The resulting formulations were fast-acting, efficacious, and highly potent with regards to suppressing the infectivity of the virus.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / chemistry*
-
Anti-HIV Agents / pharmacology*
-
Cell Line
-
Disulfides / chemistry*
-
Dose-Response Relationship, Drug
-
HIV Infections / drug therapy*
-
HIV-1 / drug effects*
-
Humans
-
Macromolecular Substances / chemistry
-
Macromolecular Substances / pharmacology
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Prodrugs / chemistry*
-
Prodrugs / pharmacology*
-
Structure-Activity Relationship
-
Time Factors
-
Zidovudine / chemistry
-
Zidovudine / pharmacology*
Substances
-
Anti-HIV Agents
-
Disulfides
-
Macromolecular Substances
-
Prodrugs
-
Zidovudine